Sat.Aug 21, 2021 - Fri.Aug 27, 2021

article thumbnail

Novartis’ Kymriah fails to hit primary survival endpoint in late-stage trial

Pharma Times

Phase III study was investigating treatment for B-cell non-Hodgkin lymphoma

146
146
article thumbnail

Older people ‘more likely to engage with digital physiotherapy care’

pharmaphorum

Researchers in the US have found that older people are far more likely to engage with digital physiotherapy programmes digitally than those in younger age groups. Gen Xers, working-age baby boomers and retirees – collectively the over-41 age bracket – were more likely to start a musculoskeletal (MSK) programme delivered via digital channels than Gen Zers and millennials, according to Hinge Health, whose back and joint pain programme was used in the study.

145
145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Ivermectin Should Not Be Used to Treat Covid, F.D.A. Says

NY Times

“You are not a horse,” the Food and Drug Administration said. “Stop it.”.

Immunity 145
article thumbnail

Inflammasome develops combo HIV/birth control implant

Outsourcing Pharma

Thanks in part to grants from the Gates Foundation, the company has come up with a bioerodible implant that combines HIV prevention and birth control.

119
119
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Existing drug could offer hope as new therapy for ALL in children

Pharma Times

Early stage research found 5-azacytidine may be used to treat 'devastating' disease

142
142

More Trending

article thumbnail

Which pharmaceutical companies have the most spray dosed drugs?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most spray dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most spray dosed drugs…. The post Which pharmaceutical companies have the most spray dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Avera Health, Sema4 join forces on precision cancer care

Outsourcing Pharma

The regional US healthcare system will collaborate with the health intelligence specialist to advance precision medicine focused on oncological care.

105
105
article thumbnail

Home antibody tests for COVID-19 to be made available in UK

Pharma Times

Up to 8,000 people per day can access the tests

142
142
article thumbnail

Digital mental health firms Headspace and Ginger in $3bn merger

pharmaphorum

A merger between two digital mental health companies – Headspace and Ginger – will create a $3 billion giant in a category that has been growing at breakneck speed as a result of the COVID-19 pandemic. The deal brings together Headspace’s meditation and mindfulness app – used by millions of people around the world – and Ginger’s platform which provides therapy and psychiatric support as an on-demand, video-based service.

122
122
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

New patent for Gilead Sciences drug EPCLUSA

Drug Patent Watch

Annual Drug Patent Expirations for EPCLUSA Epclusa is a drug marketed by Gilead Sciences Inc and is included in two NDAs. It is available from one supplier. There are twenty-six…. The post New patent for Gilead Sciences drug EPCLUSA appeared first on DrugPatentWatch - Make Better Decisions.

98
article thumbnail

Insilico Medicine uses AI to uncover preclinical candidate for kidney fibrosis

Outsourcing Pharma

The drug discovery company reportedly used AI-powered drug discovery to come up with a promising preclinical candidate for treatment of the kidney ailment.

98
article thumbnail

New BRCA-targeting drug could treat advanced prostate cancer

Pharma Times

Talazoparib delayed disease progression in Phase II trial

137
137
article thumbnail

Amplifying the patient voice for better engagement, recruitment and retention

pharmaphorum

Everyone is familiar with the phrase ‘patient-centricity’ but, where it might once have been seen as a ‘checkbox exercise’, it has gained preeminent status in the era of COVID-19, says Prime Global’s Ross Jackson. The pandemic has transformed many aspects of our industry and one area that change has come to is patient engagement within clinical trials, where it would now seem unusual were we to not consider the patient voice when it comes to recruiting trial participants.

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

New patent for Boehringer Ingelheim drug SYNJARDY

Drug Patent Watch

Annual Drug Patent Expirations for SYNJARDY Synjardy is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from one supplier. There are six patents…. The post New patent for Boehringer Ingelheim drug SYNJARDY appeared first on DrugPatentWatch - Make Better Decisions.

98
article thumbnail

MMS support program to help ultra-rare disease research

Outsourcing Pharma

The CRO has launched an initiative that offers help navigating regulatory issues for ultra-rare disease patient advocacy groups that demonstrate a need.

98
article thumbnail

Study finds protection against COVID-19 ‘waning’ in fully vaccinated people

Pharma Times

The ZOE COVID Study app assessed data on positive COVID-19 PCR test results between May and July 2021

Vaccines 130
article thumbnail

UK real-world study finds COVID-19 jab protection wanes

pharmaphorum

A study has found evidence that protection from the AstraZeneca and Pfizer/BioNTech COVID-19 vaccines starts fall off after a few months, but a UK government advisor says there’s no need to rush into a large-scale booster campaign. The results of the ZOE COVID study found that initial protection against infection a month after the second dose of the Pfizer vaccine was 88%, and after five to six months fell to 74%.

Vaccines 105
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

New patent for Boehringer Ingelheim drug SYNJARDY XR

Drug Patent Watch

Annual Drug Patent Expirations for SYNJARDY+XR Synjardy Xr is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are five…. The post New patent for Boehringer Ingelheim drug SYNJARDY XR appeared first on DrugPatentWatch - Make Better Decisions.

98
article thumbnail

WashU report highlights vulnerabilities in US pharma supply chain

Outsourcing Pharma

According to the study, the countryâs overreliance on pharmaceutical ingredients manufactured in overseas factories threatens national security and health.

98
article thumbnail

NHS to roll out same-day pre-eclampsia test for pregnant women

Pharma Times

New blood test rules out life-threatening condition

130
130
article thumbnail

Cara’s Korsuva is first drug cleared for itching in dialysis patients

pharmaphorum

One of the most common and challenging side effects for people undergoing dialysis for chronic kidney disease – chronic itching – now has an FDA-approved treatment. The US regulator has cleared Cara Therapeutics’ Korsuva (difelikefalin) as an injectable treatment for chronic itching, also known as pruritus, in these patients after a priority review.

105
105
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

New patent for Boehringer Ingelheim drug JARDIANCE

Drug Patent Watch

Annual Drug Patent Expirations for JARDIANCE Jardiance is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from four suppliers. There are six patents…. The post New patent for Boehringer Ingelheim drug JARDIANCE appeared first on DrugPatentWatch - Make Better Decisions.

98
article thumbnail

F.D.A. Fully Approves Pfizer Vaccine

NY Times

The move was expected to kick off a round of new vaccination mandates from hospitals, schools and private companies.

article thumbnail

UK study to test third COVID-19 vaccine for immunocompromised

Pharma Times

Participants will be given Pfizer, Moderna or Novavax vaccines

Vaccines 130
article thumbnail

COVID prompts another milestone, as India clears first DNA vaccine

pharmaphorum

The COVID-19 pandemic accelerated the development of mRNA-based vaccines, and its influence has now extended to DNA-based shots as well, with Zydus Cadila’s ZyCoV-D getting emergency use authorisation in India. This is the first DNA vaccine ever to receive regulatory authorisation anywhere in the world, the first COVID-19 jab approved in India to treat children aged 12 and above as well as adults, as well as the first coronavirus shot that can be administered using needle-free delivery.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.